Research output per year
Research output per year
International and National Collaboration
Publications and projects within past five years.
-
Boosting cytotoxicity of adoptive allogeneic NK cell therapy with an oncolytic adenovirus encoding a human vIL-2 cytokine for the treatment of human ovarian cancer
Quixabeira, D. C. A., Pakola, S., Jirovec, E., Havunen, R., Basnet, S., Santos, J. M., Kudling, T. V., Clubb, J. H. A., Haybout, L., Arias, V., Grönberg-Vähä-Koskela, S., Cervera-Carrascon, V., Kerkelä, E., Pasanen, A., Anttila, M., Tapper, J., Kanerva, A. & Hemminki, A., 10 Nov 2023, In: Cancer Gene Therapy. 12 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma
Murumägi, A., Ungureanu, D., Khan, S., Arjama, M., Välimäki, K., Ianevski, A., Ianevski, P., Bergstrom, R., Dini, A., Kanerva, A., Koivisto-Korander, R., Tapper, J., Lassus, H., Loukovaara, M., Mägi, A., Hirasawa, A., Aoki, D., Pietiäinen, V., Pellinen, T. & Butzow, R. & 2 others, , 16 Feb 2023, In: British Journal of Cancer. 128, 4, p. 678–690 13 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
Pikkusaari, S., Tumiati, M., Virtanen, A., Oikkonen, J., Li, Y., Perez-Villatoro, F., Muranen, T., Salko, M., Huhtinen, K., Kanerva, A., Koskela, H., Tapper, J., Koivisto-Korander, R., Joutsiniemi, T., Haltia, U.-M., Lassus, H., Hautaniemi, S., Färkkilä, A., Hynninen, J. & Hietanen, S. & 2 others, , 15 Aug 2023, In: Clinical Cancer Research. 29, 16, p. 3110-3123 14 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a human vIL-2 cytokine
Quixabeira, D. C. A., Jirovec, E., Pakola, S., Havunen, R., Basnet, S., Santos, J. M., Kudling, T. V., Clubb, J. H. A., Haybout, L., Arias, V., Grönberg-Vähä-Koskela, S., Cervera-Carrascon, V., Pasanen, A., Anttila, M., Tapper, J., Kanerva, A. & Hemminki, A., Nov 2023, In: Cancer Gene Therapy. 30, 11, p. 1543-1553 11 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Uusi työkalu räätälöityyn munasarjasyövän hoitoon
Translated title of the contribution :Functional homologous recombination assay on FFPE specimens of advanced high-grade serous ovarian cancer predicts clinical outcomes Research output: Contribution to journal › Article › Professional
Open AccessFile